FDA Invites Meeting Requests for Pilot Program to Spur Clinical Trial Innovation

Drug sponsors wishing to take part in the FDA’s pilot meeting program to discuss complex innovative trial designs (CIDs) with agency staff may now file meeting requests.
Source: Drug Industry Daily